Trial Profile
Efficacy of enzalutamide (ENZA) following abiraterone acetate (ABI) in chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC) patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Sep 2015
Price :
$35
*
At a glance
- Drugs Enzalutamide (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 24 Sep 2015 New trial record